Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

New Frontiers for Cartilage Repair and Protection.

Zaslav K, McAdams T, Scopp J, Theosadakis J, Mahajan V, Gobbi A.

Cartilage. 2012 Jan;3(1 Suppl):77S-86S. doi: 10.1177/1947603511411050.

2.

Management of Osteoarthritis with Avocado/Soybean Unsaponifiables.

Christiansen BA, Bhatti S, Goudarzi R, Emami S.

Cartilage. 2015 Jan;6(1):30-44.

3.
4.

Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination.

Ownby SL, Fortuno LV, Au AY, Grzanna MW, Rashmir-Raven AM, Frondoza CG.

J Inflamm (Lond). 2014 Mar 28;11(1):8. doi: 10.1186/1476-9255-11-8.

5.

Nutrition of the critically ill - emphasis on liver and pancreas.

Bengmark S.

Hepatobiliary Surg Nutr. 2012 Dec;1(1):25-52. doi: 10.3978/j.issn.2304-3881.2012.10.14. Review.

6.

Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis.

Henrotin Y, Pesesse L, Lambert C.

Ther Adv Musculoskelet Dis. 2014 Feb;6(1):20-34. doi: 10.1177/1759720X13514669. Review.

7.

Nutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritis.

Leong DJ, Choudhury M, Hirsh DM, Hardin JA, Cobelli NJ, Sun HB.

Int J Mol Sci. 2013 Nov 21;14(11):23063-85. doi: 10.3390/ijms141123063. Review.

8.
9.

Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study.

Maheu E, Cadet C, Marty M, Moyse D, Kerloch I, Coste P, Dougados M, Mazières B, Spector TD, Halhol H, Grouin JM, Lequesne M.

Ann Rheum Dis. 2014 Feb;73(2):376-84. doi: 10.1136/annrheumdis-2012-202485.

10.

Nutrition of the critically ill — a 21st-century perspective.

Bengmark S.

Nutrients. 2013 Jan 14;5(1):162-207. doi: 10.3390/nu5010162. Review.

11.

Anti-arthritic effects of magnolol in human interleukin 1β-stimulated fibroblast-like synoviocytes and in a rat arthritis model.

Wang JH, Shih KS, Liou JP, Wu YW, Chang AS, Wang KL, Tsai CL, Yang CR.

PLoS One. 2012;7(2):e31368. doi: 10.1371/journal.pone.0031368.

12.

Oxidative stress in secondary osteoarthritis: from cartilage destruction to clinical presentation?

Ziskoven C, Jäger M, Zilkens C, Bloch W, Brixius K, Krauspe R.

Orthop Rev (Pavia). 2010 Sep 23;2(2):e23. doi: 10.4081/or.2010.e23.

13.

Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model.

Moreau M, Rialland P, Pelletier JP, Martel-Pelletier J, Lajeunesse D, Boileau C, Caron J, Frank D, Lussier B, del Castillo JR, Beauchamp G, Gauvin D, Bertaim T, Thibaud D, Troncy E.

Arthritis Res Ther. 2011 Jun 21;13(3):R98. doi: 10.1186/ar3373.

14.

Targeting subchondral bone for treating osteoarthritis: what is the evidence?

Kwan Tat S, Lajeunesse D, Pelletier JP, Martel-Pelletier J.

Best Pract Res Clin Rheumatol. 2010 Feb;24(1):51-70. doi: 10.1016/j.berh.2009.08.004. Review.

Supplemental Content

Support Center